Id |
Subject |
Object |
Predicate |
Lexical cue |
T218 |
0-21 |
Sentence |
denotes |
SARS-CoV SARS-CoV-2 |
T219 |
22-80 |
Sentence |
denotes |
Virus origin Horseshoe bats as evolutionary reservoir host |
T220 |
81-119 |
Sentence |
denotes |
Civets as intermediate amplifying host |
T221 |
120-146 |
Sentence |
denotes |
Unknown reservoir host(s)? |
T222 |
147-202 |
Sentence |
denotes |
Rhinolophus affinis bats as evolutionary reservoir host |
T223 |
203-243 |
Sentence |
denotes |
Unknown intermediate amplifying host(s)? |
T224 |
244-270 |
Sentence |
denotes |
Unknown reservoir host(s)? |
T225 |
271-308 |
Sentence |
denotes |
Entry receptor ACE2 as entry receptor |
T226 |
309-376 |
Sentence |
denotes |
Both human ACE2 and civet ACE2 capable of supporting SARS-CoV entry |
T227 |
377-548 |
Sentence |
denotes |
Mouse ACE2 less efficient in supporting entry of SARS-CoV when compared with human ACE2 ACE2 from humans, Rhinolophus sinicus bats, civets and swine as entry receptor [35] |
T228 |
549-598 |
Sentence |
denotes |
Mouse ACE2 unable to serve as entry receptor [35] |
T229 |
599-655 |
Sentence |
denotes |
Human-to-human transmission route Droplets in most cases |
T230 |
656-695 |
Sentence |
denotes |
Close contact with contaminated fomites |
T231 |
696-707 |
Sentence |
denotes |
Faecal–oral |
T232 |
708-789 |
Sentence |
denotes |
Aerosols uncommon but possible under special circumstances Droplets in most cases |
T233 |
790-829 |
Sentence |
denotes |
Close contact with contaminated fomites |
T234 |
830-841 |
Sentence |
denotes |
Faecal–oral |
T235 |
842-900 |
Sentence |
denotes |
Aerosols uncommon but possible under special circumstances |
T236 |
901-942 |
Sentence |
denotes |
Higher attack rate within family clusters |
T237 |
943-1096 |
Sentence |
denotes |
Superspreading events Superspreading events detected in Hong Kong and Beijing [8] Superspreading events suspected as in the Diamond Princess cruise ship. |
T238 |
1097-1147 |
Sentence |
denotes |
Clinical presentations Lower respiratory infection |
T239 |
1148-1182 |
Sentence |
denotes |
ICU care required in ∼30% patients |
T240 |
1183-1204 |
Sentence |
denotes |
ARDS in ∼20% patients |
T241 |
1205-1272 |
Sentence |
denotes |
Gastrointestinal and CNS infection Lower respiratory infection [36] |
T242 |
1273-1308 |
Sentence |
denotes |
ICU care required in 5–10% patients |
T243 |
1309-1333 |
Sentence |
denotes |
ARDS in 5% patients [36] |
T244 |
1334-1360 |
Sentence |
denotes |
Gastrointestinal infection |
T245 |
1361-1385 |
Sentence |
denotes |
Asymptotic carriers [51] |
T246 |
1386-1505 |
Sentence |
denotes |
Case fatality 9.6% worldwide 3.4% worldwide as of 24 February 2020 (4.0% in Hubei Province, China, and 0.84% elsewhere) |
T247 |
1506-1540 |
Sentence |
denotes |
Transmissibility R0 = 2a R0 = 3–4b |
T248 |
1541-1662 |
Sentence |
denotes |
Interferon antagonists nsp1, nsp3, nsp16, ORF3b, ORF6, M and N proteins nsp1, nsp3, nsp16, ORF3b, ORF6, M and N proteins? |
T249 |
1663-1744 |
Sentence |
denotes |
Inflammasome activators ORF3a, ORF8b, and E proteins ORF3a, ORF8, and E proteins? |